The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Campbell David Alan since 2024.
This trader's CIK number is 1864158.
At the time of last reporting, Campbell David Alan was the President and CEO of Janux Therapeutics, Inc.. (stock ticker symbol JANX).
Also see all insider trading activities at Janux Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | JANX | 0 | $0 | 5,000 | $300,005 | 0 | $0 |
| 2024 | JANX | 0 | $0 | 90,000 | $4,811,125 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-07 | JANX | Sale | 5,000 | 60.00 | 300,005 |
| 2024-12-03 | JANX | Sale | 15,000 | 67.00 | 1,005,000 |
| 2024-11-25 | JANX | Sale | 25,000 | 51.73 | 1,293,375 |
| 2024-10-28 | JANX | Sale | 25,000 | 53.58 | 1,339,550 |
| 2024-09-27 | JANX | Sale | 25,000 | 46.93 | 1,173,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Campbell David Alan (President and CEO of Janux Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.